GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice.

about

GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice.

Item

http://www.wikidata.org/entity/Q47745704

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

GUB06-046, a novel secretin/gl ...... ta cell mass in diabetic mice.

@en

GUB06-046, a novel secretin/gl ...... ta cell mass in diabetic mice.

@nl

type

Item

label

GUB06-046, a novel secretin/gl ...... ta cell mass in diabetic mice.

@en

GUB06-046, a novel secretin/gl ...... ta cell mass in diabetic mice.

@nl

prefLabel

GUB06-046, a novel secretin/gl ...... ta cell mass in diabetic mice.

@en

GUB06-046, a novel secretin/gl ...... ta cell mass in diabetic mice.

@nl

P1476

GUB06-046, a novel secretin/gl ...... eta cell mass in diabetic mice

@en

P2093

Gitte Hansen

http://www.w3.org/2001/XMLSchema#string

Søren B van Witteloostuijn

http://www.w3.org/2001/XMLSchema#string

P2860

Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system

Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat

The mechanism of pancreatic secretion

Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity

The Physiology of Glucagon-like Peptide 1

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

Immunofluorescent localization of secretin and enteroglucagon in human intestinal mucosa.

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

P304

845-854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PSC.3048

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Grethe Vestergaard Jensen

P577

2017-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29057588

http://www.w3.org/2001/XMLSchema#string